• Renovaro added Avram Miller, Leni Boeren, Ruud Hendriks, to the company’s board of directors
• The three additions bring extensive financial backgrounds that will help as the company ventures into the new agreement with GEDiCube and Renovaro AI branding
• Avram Miller believes that Renovaro Bioscience, combined with GEDiCube, has the key elements to play a significant role in transforming AI’s impact on medicine

Renovaro Biosciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene, and immunotherapy focused on solid tumors with short life expectancy, recently announced a definitive agreement to combine with the advanced AI Company GEDiCube Intl Ltd., rebranding as Renovaro AI. The company has also announced the addition of three new members to its board of directors – Avram Miller, Leni Boeren, and Ruud Hendriks.

Leni Boeren brings a 40-year career in the financial sector, with banking roles at Paribas and Rabobank. She has held several director-level positions at Amsterdam Exchanges and Euronext, the first pan-European stock and derivatives exchange resulting from the merger of exchanges in Amsterdam, Paris, and Brussels. After these roles, she transitioned to asset management, spending over a decade undertaking executive roles, including CEO and Chair of the international Robeco Groep N.V. and holding board of directors seats for the group’s subsidiaries. Boeren currently holds several advisory roles, including the Capital Market Committee of the Dutch regulator, the Authority for the Financial Markets.

Boeren said she was excited to join the Board for Renovaro Biosciences as it moves towards combining with GEDiCube. “I look forward to supporting the company in unlocking the vast potential of the two companies. Together, we are committed to spearheading advancements in the battle against cancer and other diseases, harnessing cutting-edge AI technology and pioneering biotherapeutics,” Boeren added (https://ibn.fm/o1anO).

Ruud Hendriks brings over 35 years of experience in asset management, having held senior roles at some of the most established financial institutions. This includes a decade at Goldman Sachs Asset Management, which he joined as a managing director, becoming co-head of sales for Europe, the Middle East, and Africa. Before this, he worked at Robeco Group, including Rodamco, the property fund of the Robeco Group, before becoming Senior Vice President and Global Head of Institutional Sales at Robeco. He also advises wealthy individuals next to being an Ambassador to Add Value Fund Management B.V.

Avram Miller is an American businessperson, corporate venture capitalist, scientist, and technologist who served as vice president of Business Development for Intel Corporation and co-founded Intel Capital, a division of Intel Corporation set up to manage corporate venture capital, global investment, mergers, and acquisition. Before his career in High-Tech, he had a 13-year career in medical science. For the last decade, Miller has re-engaged his interest in utilizing technology in health care, advising prominent institutions like the Cleveland Clinic and Sheba Medical Center coaching and investing in many early-stage Med-Tech startups.

Most importantly, according to Miller, the impact of AI on medicine will be as significant as the impact of the Internet on the computer industry. “I was fortunate to play a role in that, and now I am excited to have a similar opportunity. We are at an inflection point. AI should lead to personalized medicine comprised of new diagnostics and treatments, which will have a profound impact on longevity and, in particular, health span, something I care deeply about,” Miller added (https://ibn.fm/CW1pe). “I believe that Renovaro Bioscience, combined with GEDiCube, has the key elements to play a significant role in this transformation. I am delighted to have the opportunity to assist the company as a board member and an advisor working closely with the company’s leadership team.”

For more information, visit the company’s website at www.RenovaroBio.com.

NOTE TO INVESTORS: The latest news and updates relating to RENB are available in the company’s newsroom at https://ibn.fm/RENB

• U.S. regulatory agencies are fining banks and other financial institutions millions of dollars for privacy violations
• Fines range up to $50 million per occurrence, but Sekur’s services offer an immediate and cost-effective solution to avoid fines
• Sekur offers Chat-by-Invite, SekurMessenger, and SekurMail as a fully encrypted communications platform that financial institutions can utilize to safeguard their data and comply with U.S. regulations

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0), a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure and private communications, was recently featured on the New to the Street segment “Sekur Privacy & Sekur Security Segment – The Weekly Hack” (https://ibn.fm/JiVFd). Sekur’s internationally acclaimed internet privacy expert and CEO Alain Ghiai was interviewed by host and multi-media journalist Ana Berry about U.S. regulatory agencies fining banks and other financial institutions millions of dollars for bank privacy violations.

Under U.S. regulation, financial entities cannot communicate with clients and their employees using non-secure, open text, and email platforms – with an SEC probe discovering financial institutions using WhatsApp to communicate private banking matters. Fines can range up to $50 million per occurrence for using non-secure e-communication platforms, but the segment concludes that with Sekur’s Chat-by-Invite feature, SekurMessenger, and SekurMail, there is an affordable and immediate cost-effective solution financial institutions can use to avoid being fined.

In 2022, the global cyber security market was valued at $173.5 billion and is expected to reach $266.2 billion by 2027, growing at a CAGR of 8.9% (https://ibn.fm/J4C3x). This market is being driven by the increased number of data breaches worldwide, with the ability of malicious characters to operate from anywhere in the world – making the need for secure and encrypted communications occur, especially in the financial industry where personal and vulnerable data is constantly being communicated daily.

With the shift to a work-from-home landscape, vulnerabilities, especially where financial data is concerned, have become an easy target when not using high-level encryption. When using Sekur’s suite of services, customer information is stored confidentially and safely in Switzerland using military-grade security. Sekur chose Switzerland due to its very tough privacy laws – as a company, Sekur never tracks devices, doesn’t ask for phone numbers, doesn’t use third-party platforms, and never sells data to third-party companies.

Mr. Ghiai explains during the segment that, with Sekur, financial entities can communicate with clients on the company’s fully secure encrypted platform:

• Invites to Sekur’s Chat-by-Invite allow clients to receive an invite to communicate without downloading apps using Sekur’s closed-loop platform.
• The SekurMessenger SMS platform is available in 83 countries, allowing financial institutions protection under US laws when communicating with overseas clients.
• SekurMail is an encrypted email service that allows for communication, whether through Sekur’s ecosystem or outside of it, that is secured and encrypted – safeguarding communications regardless of geographical or political barriers.

He also recommends SekurVPN, a virtual private network hosted on the company’s 100 %-owned servers in Switzerland. Subscribers will always appear as being in Switzerland, with web traffic never traced or information sold to third parties. Financial institutions and other interested parties can get a 15% savings monthly and yearly on all of Sekur’s service plans, which is good for five years, using the Promo Code: PRIVACY.

The new weekly interviews between Ms. Berry and Mr. Ghiai air on Bloomberg TV 2 Saturdays a month at 6:30PM EST and on the Fox Business Network every Sunday at 3:30 to 4:00 PM EST (with the Sekur segment airing usually the last 10 minutes) – and are available now for replays at https://newtothestreet.com/?s=skur.

For more information, visit the company’s website at www.SekurPrivateData.com.

NOTE TO INVESTORS: The latest news and updates relating to SWISF are available in the company’s newsroom at https://ibn.fm/SWISF

• PaxMedica, with the help of financial services firm Bourne Partners, is actively exploring presale of its Priority Review Voucher (“PRV”), highly valuable in the pharmaceutical marketplace once it gets formal approval from the FDA
• The move is the next step in PaxMedica’s ongoing commitment to advancing innovative healthcare solutions for autism patients worldwide
• Similar successful endeavors in the pharmaceutical landscape have demonstrated lucrative potential

PaxMedica (NASDAQ: PXMD), a pioneering biopharmaceutical company focused on advancing treatments for neurologic disorders, has set its sights on an exciting potential opportunity. With the engagement of Bourne Partners, a prominent financial services firm specializing in the pharmaceutical and consumer health sectors, PaxMedica is actively exploring the presale of its Priority Review Voucher (“PRV”).

The Food and Drug Administration (“FDA”) can approve and award a priority review vouchers to drug sponsors that develop drugs for rare pediatric or tropical diseases. Such vouchers have value, providing for expedited regulatory review, and can be sold for significant sums in the pharmaceutical marketplace. This strategic move aligns with PaxMedica’s ongoing commitment to advancing innovative healthcare solutions for autism patients worldwide.

As the industry eagerly awaits the FDA decision on PaxMedica’s groundbreaking developments, the potential sale of the PRV could serve as a significant milestone for the company. Similar successful endeavors in the pharmaceutical landscape have demonstrated the lucrative potential of such transactions. In recent industry news, Novartis’s planned acquisition of a PRV from bluebird bio for an impressive $103 million highlights the growing value of PRVs in the evolving healthcare sector. This strategic maneuver not only reflects the industry’s persistent drive for pioneering progress but also underscores the increasing significance of PRVs as pivotal assets in the pharmaceutical landscape.

PaxMedica’s collaboration with Bourne Partners underscores the company’s dedication to maximizing its resources and optimizing its assets to support the development of groundbreaking autism treatments and research initiatives. With an established reputation for facilitating the efficient movement of capital through the global healthcare industry, Bourne Partners brings valuable insights and expertise to the table, positioning PaxMedica for a successful PRV presale and future advancements in neurology.

For more information, visit the company’s website at www.PaxMedica.com.

NOTE TO INVESTORS: The latest news and updates relating to PXMD are available in the company’s newsroom at https://ibn.fm/PXMD

• Application showed an improvement of 50% in customer rewards program effectiveness for the same amount of budget
• Italian fintech company Satispay anticipates that its internal teams will use the application weekly when the company transitions it into production
• D-Wave’s suite of services is backed by two decades of quantum technology development and over ten years of customer feedback, which have been incorporated to create the industry’s first quantum computer designed for commercial business applications

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, recently announced that it is working with Satispay, the leading Italian fintech unicorn revolutionizing mobile payments, to build a quantum-hybrid application designed to optimize customer rewards initiatives (https://ibn.fm/u15OM).

Using D-Wave’s constrained quadratic model (“CQM”) hybrid solver, the application showed an improvement of 50% in customer rewards programs for the same amount of budget – identifying more effective approaches to Satispay’s rewards programs and the goal of increasing membership of its payment network.

Satispay’s internal teams are anticipating to use the application weekly when the company transitions it into production. The quantum-hybrid application comes as Satispay’s adoption is on the rise in countries including Italy and France – with consumers and businesses looking for a seamless, secure, and easy way to send, receive, and spend money.

Murray Thom, vice president of quantum business innovation at D-Wave, underlined that digital payments are one of the fastest-growing developments in financial services. “By applying the power of quantum-hybrid technology to optimize Satispay’s customer acquisition strategies, D-Wave is assisting one of Europe’s top fintech companies unlock a competitive advantage and bring its independent payment network to more customers, faster,” Thom added.

The D-Wave Advantage(TM) quantum computer is built from two decades of quantum technology development and over ten years of customer feedback to deliver the first quantum computer designed for commercial business applications. The system features a processor architecture with over 5,000 qubits and 15-way qubit connectivity. Since 2018, Advantage has been available to users through the Leap(TM) quantum cloud service – which delivers immediate, real-time access to Advantage and the company’s quantum hybrid solver service with enterprise-class performance and scalability.

“It is our mission at Satispay to simplify payments to improve everyone’s life, and we’re looking at innovative ways we can accelerate adoption and usage of our network to quickly build out our market footprint in service of that vision,” said Satispay founder and CEO Dario Brignone. “Together with D-Wave, we’ve built a quantum-hybrid application that has demonstrated immediate business value at scale, helping us more effectively manage our rewards program to save money, improve rewards appreciation, and drive increased membership.”

Leap enables developers proficient in Python to start building and running quantum applications today. The secure and seamless cloud-based connection allows users to easily start solving complex problems of up to one million variables and 100,000 constraints. D-Wave’s CQM hybrid solver is available through its Leap quantum cloud service.

D-Wave’s relentless pursuit of practical quantum computing has resulted in its technology being used today by some of the world’s most advanced enterprises – including numerous Forbes Global 2000 companies. D-Wave’s commercial customers include blue-chip industry leaders like Mastercard, Deloitte, ArcelorMittal, Siemens Healthineers, Unisys, Accenture, BBVA, NEC Corporation, Pattison Food Group Ltd., DENSO and Lockheed Martin.

D-Wave’s four-step Launch(TM) program uses an in-house professional services team and technical domain experts to help businesses accelerate enterprise quantum adoption and realize value faster. Through this hands-on consultative approach, customers receive support with problem discovery, quantum proof of concept, production pilot, and in-production deployment. D-Wave enables customers to build quantum applications capable of solving real-world business problems today. The company showcases customer success stories that demonstrate how quantum technology has been applied to various problems ranging from grocery optimization to protein design at https://ibn.fm/q0HjI.

For more information, visit the company’s website at www.DWaveQuantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward-Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. Forward-looking statements in this press release include, but are not limited to, statements regarding Satispay’s plans to transition the application to production, the expected usage of the application by Satispay’s internal teams, and the potential impact of the application once in production. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the usage of the application by Satispay’s internal teams and the continued positive impact of the application once in production; general economic conditions and other risks; the company’s ability to expand its customer base and the customer adoption of the company’s solutions; risks within D-Wave’s industry, including anticipated trends, growth rates, and challenges for companies engaged in the business of quantum computing and the markets in which they operate; the outcome of any legal proceedings that may be instituted against the company; risks related to the performance of D-Wave’s business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and/or timing thereof; the performance of the company’s products; the effects of competition on the company’s business; the risk that D-Wave will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the company may never achieve or sustain profitability; the risk that the company is unable to secure or protect its intellectual property; volatility in the price of the company’s securities; the risk that the company’s securities will not maintain the listing on the NYSE; and the numerous other factors set forth in D-Wave’s Annual Report on Form 10-K for its fiscal year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to the company on the date hereof. The company undertakes no duty to update this information unless required by law.

• Rat populations have created concerns for centuries because of their potential to be a vector for diseases, their destruction of infrastructure, and their consumption or spoilage of stored food supplies
• Arizona-based SenesTech Inc. is now introducing its new Evolve(TM) Soft Bait as a companion to its patented ContraPest(R) liquid product as means of shifting rodent control methods from lethal poisons to preventative birth control formulations, with Evolve(TM) Soft Bait representing a big step into a major new market
• The company recently discussed its operation and plans for the near future during a webcast presentation as part of Lytham Partners’ Fall 2023 Investor Conference
• SenesTech has produced successes during testing at West Coast and East Coast poultry farms, and has achieved new client agreements that extend to the countries of Maldives and South Africa

Rodent control innovator SenesTech (NASDAQ: SNES) is delivering a new method of administering its unique, patented contraceptive technology that serves as a form of birth control in both male and female rats, making SenesTech’s solution to the rat population more readily accessible and appealing to pest management companies as well as consumers who prefer non-liquid baits.

The company’s new trademarked Evolve(TM) Soft Bait is an important non-liquid addition to SenesTech’s portfolio, which includes the liquid ContraPest(R) bait brand that has been its flagship product (https://ibn.fm/KhoQm). Since non-liquid forms of control products are preferred by rodent control professionals, Evolve(TM) Soft Bait is a strong entry for the company into this huge new market.

SenesTech CEO Joel Fruendt and CFO Tom Chesterman discussed the strategy behind Evolve(TM) in a Lytham Partners Fall 2023 Investor Conference webcast presentation earlier this month (https://ibn.fm/xmDqm).

While ContraPest(R) has been “very palatable” to rodents and “keeps the rats coming back for more,” Fruendt said, only about 5 percent of current rodenticide formulations are in liquid form — the vast majority of the market uses solids. Pest management businesses represent a significant market for SenesTech’s new product.

“. . . we are … releasing a soft bait formulation which provides the unique attributes of proven fertility control in an industry-familiar soft bait format demanded by many, including big box retailers, key e-commerce channels and leading pest management professionals,” Fruendt said. “When I took over as CEO at SenesTech, soft bait is one of the key items I quickly identified as a need for us to steepen the curve. I believe its introduction … will be transformative for our business.”

Fruendt labeled rodent control “one of the world’s most challenging problems,” but noted solutions have thus far focused on lethal poisons that “seek to control the death rate” with limited success.

“The challenge, as we see it, is the incredible rate of reproduction of the rats. Given sufficient food, water and harborage, two breeding rats can result in 15,000 offspring after a single year,” he said. “In fact, the largest pest company in the world, Rentokil, commissioned an interactive study, The Rise of Rats, that revealed how a pair of rats could produce nearly half a billion descendants in just three years,” Fruendt added. “Half a billion! You cannot poison them, or trap them or gas them fast enough to overcome their fertility.”

Evolve(TM) will be available for direct sale to pest management professionals, and to the broader consumer market through distributors, on the company’s e-commerce portal and through big box retailers.

The company expects agribusiness and the pest management industry to be crucial to its future success. Currently, about 50 percent of its revenue comes from small e-commerce orders. SenesTech also sees potential in local government partnerships.

“As we are seeing significant increases within the government vertical driven by deployments in California and New England, our experience here is that our customers in the government sector require a longer sales cycle but are very sticky once they get on board. Hopefully, this will provide us a long-term tail wind,” Fruendt said.

Chesterman noted that the company’s most recent financial report for Q2 showed that revenue was up 31 percent sequentially compared to Q1, and Fruendt noted revenue has been consistently growing with an 87 percent CAGR over the past few years.

“We’ve experienced rapid growth over the past few years,” Chesterman said.

“Most recent trends confirm that growth is accelerating as our initiatives put place in the first half of the year take hold,” he added. “Our current goal is to take $1 million out of the annual cash expenses and we’re well on our way to achieving that goal. … (And) we have no long-term debt.”

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

Serious investors — and anyone concerned with protecting and building wealth in volatile times — invited to attend the New Orleans Investment Conference to be held in New Orleans, November 1-4, 2023.

With a rich legacy spanning almost 50 years, the New Orleans Investment Conference has been acclaimed as “The Greatest Investment Show on Earth” by Money Magazine. Held in the heart of New Orleans, the 2023 Conference is set to present a dream team of world-class experts on geopolitics, macroeconomics and every asset class to hundreds of savvy investors.

The 2023 Conference will feature enlightening presentations from leading experts such as Konstantin Kisin, Matt Taibbi, Jim Rickards, Danielle DiMartino Booth, Lyn Alden, George Gammon, Rick Rule, Dominic Frisby, Brent Johnson, Dave Collum, Peter Boockvar, James Stack, Peter Schiff, Jim Iuorio, Tavi Costa, Adrian Day, Adam Taggart, The Real Estate Guys, Gwen Preston, Brent Cook, Brien Lundin, and many more. Early bird registration is still open, offering significant savings for those who secure their spots early.

To learn more, please visit https://ibn.fm/ISvQC

• The UK’s criminal justice department recently announced that domestic abusers leaving prison will be wearing electronic monitoring tags for better victim protection
• Up to 500 offenders will be forced to wear GPS and curfew tags to monitor their movements, with those who breach the stipulated license conditions being returned to prison
• This move by the UK validates digital monitoring solutions such as SuperCom’s Electronic Monitoring (“EM”) products
• It also shows the technology’s viability in solving emerging issues while also validating SuperCom’s research and development efforts as targeting an active and growing world market

SuperCom (NASDAQ: SPCB), a global provider of traditional and digital identity solutions offering advanced safety, identification, and security products and solutions to governments, is constantly pushing the envelope with innovation and exploring new markets for its products. This ambition has been driven by its mission and commitment to “creating safer communities”. More nations globally are beginning to realize the need for more advanced technologies to manage offender populations, representing a significant growth opportunity for SuperCom.

In September 2023, the UK’s criminal justice department announced that domestic abusers leaving prison would wear electronic monitoring tags to offer better victim protection. The plan, which will first launch in East and West Midlands, will see up to 500 offenders forced to wear GPS or curfew tags to monitor their movements upon leaving prison. Offenders who breach the stipulated license conditions will face being returned to prison.

“Survivors of domestic abuse show great strength and bravery in coming forward, and it is right that every tool is used to protect them from further harm,” noted the lord chancellor and justice secretary, Alex Chalk.

“The tagging of prison leavers at risk of committing further domestic abuse is a further protection we are introducing to help victims rebuild their lives and feel safe in their communities,” he added (https://ibn.fm/JjWky).

In the case of SuperCom, the company recently announced it has secured a new national program with the government of Finland. The Finnish government announced that domestic violence offenders will wear Domestic Violence Monitoring Solutions as a way to safeguard victims, proactively prevent domestic violence, and empower Finnish authorities with advanced tech that promises to enhance the safety and well-being of the country’s citizenry (https://ibn.fm/8K6hA). It adds to the country’s use of electronic ankle bracelets, introduced in 2011, and electronic monitoring for offenders found repeatedly guilty of drunk driving.

UK’s move to adopt advanced monitoring solutions validates these technologies, specifically SuperCom’s family of Electronic Monitoring (“EM”) products. It showcases the potential application of this technology and its viability in solving emerging security issues within countries. More importantly, it is encouraging the efforts of companies such as SuperCom to continue developing technological solutions that steer society towards being safer and protecting domestic abuse victims from their abusers.

The UK is already witnessing positive results from a prison scheme launched last summer that prevented unwanted prisoner contact with the victims by blocking the victims’ numbers’ from prison phones and preventing the former from sending threatening letters to the victims’ addresses. The government pointed out that over 2,700 victims had been protected from further harassment, which has helped further accentuate the potential of GPS and curfew tags on domestic abusers leaving prison.

With the initial launch in the East and West Midlands, the UK plans to roll out the monitoring tags across England and Wales in 2024. The government is optimistic that the positive results will allow victims to rebuild their lives and feel safe in their communities.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

Investors, policymakers, enthusiasts, technologists, decision-makers, and business owners are invited to attend the New Orleans Investment Conference to be held in New Orleans, Louisiana, November 1-4, 2023. The 2023 edition of this iconic event is committed to paving the way to real investment insights and financial wisdom in a fast-changing economic landscape. Having a rich history of successful investment symposiums, the New Orleans Investment Conference has consistently brought together some of the brightest minds in finance, politics, and economics. The conference will feature a lineup of world-renowned speakers who will share valuable investment strategies to unlock the secrets of financial success. Sharing a Legacy of Financial Success Amidst the growing economic uncertainties, the New Orleans Investment Conference serves as a beacon of unmatched investment opportunities. The visionaries will cover a wide range of topics, from real estate, geopolitics, precious metals, and commodities to cryptocurrency, and more. The diverse lineup of eminent thought leaders includes:

• Lyn Alden – one of today’s most insightful macro-economic analysts.
• Peter Boockvar – a respected market analyst known as the ‘resident contrarian’ on CNBC.
• Danielle DiMartino Booth – CEO and Chief Strategist at QI Research, and notably, a former Fed insider who served as an advisor to the Dallas Fed for a decade.
• Dominic Frisby – a financial writer and celebrated comedian, renowned for his YouTube presence and authorship of multiple books, including “Bitcoin: The Future of Money?”
• George Gammon – a highly successful American real estate investor, renowned for his show, “The Rebel Capitalist Show.”
• Jim Iuorio – a renowned trader and outspoken market analyst featured on CNBC and Fox News.
• Brent Johnson – CEO of Santiago Capital, famed for his dollar-milkshake theory.
• Konstantin Kisin – a popular political and lifestyle commentator with a massive global following.
• James Rickards – Editor of “Strategic Intelligence,” a financial newsletter, and author of seven best-selling books.
• Matt Taibbi – author of four New York Times bestsellers and an award-winning columnist for Rolling Stone.
• Peter Schiff – widely recognized as an economic and financial analyst who accurately forecasted the real estate bubble and the 2008 financial crisis, and the author of several best-selling books.
• Rick Rule – a global thought leader in the commodities sector, renowned as perhaps the most successful resource speculator.
• Robert Prechter – author of the classic “Elliott Wave Principle” and founder of Elliott Wave International.

From in-depth keynote presentations to interactive sessions, the New Orleans Investment Conference offers insightful financial information that spans the whole investment spectrum. Attendees will get an opportunity to connect with industry experts, like-minded investors, and visionary entrepreneurs. They can forge lasting relationships, explore economic trends, and dissect policy changes to make truly informed investment decisions. To learn more, please visit https://ibn.fm/ISvQC

• Freight Technologies (“Fr8Tech”) is a North American transportation logistic technology company
• The company is keen on simplifying cross-border shipping in the U.S.-Canada-Mexico Agreement (“USCMA”) region by capitalizing on the advanced capabilities of its Fr8App platform
• Fr8App seamlessly connects shippers in the U.S., Canada, and Mexico with an extensive network of reliable carriers and drivers
• Through Fr8App, Fr8Tech is participating in the trucking and freight market’s ongoing paradigm shift, which has seen more and more shippers opt for brokerage services instead of dealing directly with carriers
• Freight brokers are handling over 20% of all trucking freight, up from 6% in 2000

Freight brokers are changing the face of the trucking industry, upending decades-old preferences that previously forced them to operate on the fringes. Brokers now handle over 20% of all trucking freight, up from 6% in 2000. This growth is attributed partly to brokerages’ investments in customer service and technology, which enabled them to offer a “more compelling product” than asset-based carriers and take on a “greater role in routing guides,” according to a recent article (https://ibn.fm/zdexO). As a result, brokers now handle higher quality cargo than in 2000 and are often assigned highly desirable, carrier-friendly freight.

The growth is also due to a number of other factors, chief among them being the fact that brokerages have built extensive databases of reliable carriers and frequent shippers. This means that shippers can lean on brokers for reliable carriers who will ensure their loads are shipped and delivered on time. On the other hand, carriers look to brokerages for a continual supply of business.

On top of providing reliable leads, the role of brokers has also expanded. Freight brokers manage traffic for shippers and act as sales agents for carriers. They also take on sales and customer service roles that are too expensive for small carriers – which make up about 97% of the roughly 531,000 carriers in the U.S. – to afford.

But perhaps more importantly, freight brokerages provide a regular flow of freight for many of these small carriers. In fact, freight brokers have been able to maintain load volumes even when the trucking market has softened in what has altered the typical freight cycle. Combined, these factors are increasingly making freight brokers indispensable, effectively turning the tide.

Participating in the trucking and freight market’s paradigm shift is Freight Technologies (NASDAQ: FRGT), often abbreviated as Fr8Tech, a North American transportation logistics technology company. Through its primary operating subsidiary, Fr8App, a cutting-edge digital broker, Fr8Tech is simplifying cross-border shipping in the U.S.-Canada-Mexico Agreement (“USCMA”) region.

Fr8App utilizes one of the most connected and intelligent freight-matching platforms, eponymously named Fr8App. The platform seamlessly connects shippers in the U.S., Canada, and Mexico, with an extensive network of reliable carriers and drivers, ensuring reliable and efficient freight transportation. It promises competitive and transparent prices – charging fixed rates with no hidden fees – and prescreens each carrier on multiple criteria to make sure they meet the desired standards and safety checks.

With live 24/7 GPS tracking on desktop or mobile, Fr8App provides complete visibility of shipments as they traverse country and state borders. But that’s not all. The platform’s chat feature facilitates real-time, direct, and constant communication between shippers and carriers, enhancing coordination. Fr8App offers other features, including route optimization, payment management, and advanced data analytics.

As freight brokers continue to revolutionize the trucking industry, playing the increasingly indispensable role of matching shippers with reliable carriers, Fr8Tech’s Fr8App is staking a claim by harnessing the power of its advanced technology, real-time capabilities, and an extensive suite of features.

For more information, visit the company’s website at www.Fr8Technologies.com and its freight matching platform information site at www.Fr8.App.

NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT

Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

• Lexaria, a global innovator in drug delivery platforms, just announced an exclusive license to SulfoSyn Limited to use its patented DehydraTECH(TM) technology
• Lexaria will also perform specific DehydraTECH-related manufacturing operations on SulfoSyn’s behalf for an initial term of 2 years
• The license agreement adds to Lexaria’s growing list, which, as of the last two years, includes BevNology LLC, Premier Wellness Science Co. Ltd., and Dehydr8, LLC, among others
• It highlights the superiority of Lexaria’s technology, as further compounded by the 37 patents granted so far

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its latest global, exclusive license to SulfoSyn Limited to use its patented DehydraTECH(TM) technology. This license will allow SulfoSyn to use Lexaria’s technology in non-pharmaceutical uses of sulforaphane worldwide, with the ability to sub-license its rights to other companies (https://ibn.fm/E48bP).

This agreement is the product of months of research for the two entities. In late 2022, both Lexaria and SulfoSyn started exploring the applicability of DehydraTECH upon sulforaphane. This Sulphur-rich composite molecule is commonly found in vegetables such as broccoli, kale, and cabbage. The testing established that DehydraTECH did have certain superior qualities on the sulforaphane molecule, a result that showed the technology’s commercial viability, specifically for SulfoSyn.

As a result, SulfoSyn will be at liberty to use the DehydraTECH technology for various non-pharmaceutical uses, including supplements, foods, additives, dietary ingredients, and more. In addition, Lexaria has also been contracted by the company to perform specific DehydraTECH-related manufacturing operations on behalf of SulfoSyn for an initial term of 2 years, an engagement that will see Lexaria increase its revenue.

An up-front cash payment has since been paid by SulfoSyn, with minimum future payments already agreed to. In addition, the licensing agreement will see an ongoing royalty payment generated once the minimum payments are exceeded.

This license agreement with SulfoSyn adds to Lexaria’s growing list, which, in the last two years, includes BevNology LLC, Premier Wellness Science Co. Ltd., and Dehydr8, LLC, among others. Given the company’s focus on licensing its technology to companies worldwide, this latest addition marks a significant milestone while highlighting its current growth trajectory, particularly as it continues to create value for its shareholders.

In addition, this milestone highlights the superiority of Lexaria’s DehydraTECH technology, as further compounded by the patents received so far and the pending patents worldwide. On August 29 and September 26, the company received its latest new patents in Canada, bringing the total number of granted patents to 37. Even so, Lexaria continues to invest heavily in its research and development (“R&D”), exploring the potential usage of its technology in various areas of application, including nicotine replacement, antivirals, cardiovascular drugs, human hormone delivery, CBD, PDE5 inhibitors and more.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX